Safety and efficacy of durvalumab after concurrent chemoradiation in Black patients with locally advanced non-small cell lung cancer.

Cancer（2023）

引用 1|浏览29

暂无评分

摘要

The efficacy and tolerability of consolidative durvalumab after chemoradiation appears to be comparable between Black and non-Black patients.

查看译文

关键词

chemoradiation, durvalumab, immunotherapy, non-small cell lung cancer, race

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要